Quality control in centralized cytotoxic reconstitution unit: Dream or reality?;Le contrôle de qualité en unité centralisée de reconstitution des cytotoxiques: Mythe ou réalité?

S.T.P. Pharma Pratiques

Volumn 15, Issue 2, 2005, Pages 148-160

  Havard, Laurent ^a   Bonan, Brigitte ^a   Huen, Jean Michel ^b   Roche, Yves ^c   Prognon, Patrice ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b Varian SA   (France)

^c Cenexi   (France)

Author keywords

Compounded hazardous; Compounding Units; HPLC; Quality assurance; Sampling strategy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYTARABINE; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; OXALIPLATIN; PACLITAXEL; RITUXIMAB; TRASTUZUMAB; VINCRISTINE;

ARTICLE; AUTOMATION; CANCER RESEARCH; DRUG MANUFACTURE; MICROBIOLOGICAL EXAMINATION; PHARMACY; QUALITY CONTROL;

EID: 21744441221     PISSN: 11571497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bouligand, J., et al., High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical products. J Pharm Biomed Anal, 2004. 34(3): p. 525-30.
2. Bouma, M., et al., Development of a LC method for pharmaceutical quality control of the antimetastatic ruthenium complex NAMI-A. J Pharm Biomed Anal, 2003. 31(2): p. 215-28.
3. Bourget, P., et al., Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unit. Eur J Pharm Biopharm, 2003. 56(3): p. 445-51.
4. Paci, A., L. Mercier, and P. Bourget, Identification and quantitation of antineoplastic compounds in chemotherapeutic infusion bags by use of HPTLC: application to the vinca-alkaloids. J Pharm Biomed Anal, 2003. 30(5): p. 1603-10.
5. De Fusco, M., et al., High-performance liquid chromatographic assay for the determination of the novel etoposide derivative dimethylaminoetoposide (NK611) and its metabolites in urine of cancer patients. J Chromatogr B Biomed Appl, 1995. 664(2): p. 409-14.
6. Escoriaza, J., et al., Simple and sensitive determination of 5-fluorouracil in plasma by high-performance liquid chromatography. Application to clinical pharmacokinetic studies. J Chromatogr B Biomed Sci Appl 1999. 736 (1-2): p. 97-102.
7. He, X., et al., Determination of procarbazine in human plasma by liquid chromatography with electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci., 2004. 799(2): p. 281-91.
8. Willey, T.A., et al., High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol) in human plasma. J Chromatogr, 1993. 621(2): p. 231-8.
9. Mader, R.M., et al., Determination of methotrexate in human urine at nanomolar levels by high-performance liquid chromatography with column switching. J Chromatogr, 1993. 613(2): p. 311-6.
10. ICH, Texton validation of analytical procedures: methodology. ICH Harmonised Tripartite Guideline, 1996. 4: p. 1-8.